Company Update (NASDAQ:CERN): Cerner to Present at JP Morgan Healthcare Conference

[GlobeNewswire] – KANSAS CITY, Mo., Jan. 05, 2016– Cerner Corporation invites you to listen to the live broadcast of the company’ s presentation at the JP Morgan Healthcare Conference in San Francisco on Jan. 12, at 11 … Read more on this. Cerner Corporation (CERN) , currently valued at $19.95B, opened this morning at $58.09. A quick look at the market, the company’s stock traded between $58.03 and $58.65 and has traded between $55.82 and $75.72 over the past 12 months. CERN shares are currently priced at 28.10x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 4.55x earnings multiple. In a review of the consensus earnings estimate this quarter, 27 sell-side analysts are looking at $0.57 per share, which would be $0.10 better than the year-ago quarter and a $0.04 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $2.07 would be a $0.42 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $1.17 Billion. If realized, that would be a 26.35% increase over the year-ago quarter. In terms of ratings, Topeka Capital Markets upgraded CERN from Hold to Buy (Sep 8, 2015). Previously, Stifel downgraded CERN from Hold to Sell. With the above information in mind, readers should note that the average price target is $69.98, which is 20.47% above where the stock opened this morning. See more in (NASDAQ:CERN) Similar Articles: Market Update: Cerner Corporation (NASDAQ:CERN) – Cerner (CERN) Stock Falls on Weak Guidance Stock Update: Cerner Corporation (NASDAQ:CERN) – Cerner (CERN) Stock Down in After-Hours Trading on Earnings Results Company Update: Cerner Corporation (NASDAQ:CERN) – Nearly 14,000 to Attend Annual Cerner Health Conference, Oct. 11-14
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.